Table 1 Patients’ characteristics

Patient number, n

21

14

7

/

Gender, n (%)

0.61

 Male

15 (71)

9 (64)

6 (86)

 Female

6 (29)

5 (36)

1 (14)

ECOG, n (%)

 0–1

21 (100)

14 (100)

7 (100)

1.00

Social conditions, n (%)

besser

0.33

 Accompanying person available

20 (95)

14 (100)

6 (86)

 Single

1 (5)

0 (0)

1 (14)

Implanted port catheter, n (%)

0.53

 yes

19 (90)

12 (86)

7 (100)

 no

2 (10)

2 (14)

0 (0)

Diagnosis of MM

 Age at first diagnosis, years

58 (43–67)

57 (43–67)

59 (47–66)

0.85

Stage at first diagnosis III, n (%)

1.00

 A

21 (100)

14 (100)

7 (100)

 B

0 (0)

0 (0)

0 (0)

Heavy chain type, n (%)

0.34

 IgG

11 (52)

9 (64)

2 (29)

 IgA

9 (43)

5 (36)

4 (57)

 Light chain only

1 (5)

0 (0)

1 (14)

0.33

Light chain type, n (%)

1.00

 κ

13 (62)

9 (64)

4 (57)

 λ

8 (38)

5 (36)

3 (43)

Induction therapy, n (%)

0.61

 PAD

10 (48)

5 (36)

5 (71)

 VAD

2 (10)

2 (14)

0 (0)

 VCD

8 (38)

6 (43)

2 (29)

 Other

1 (5)

1 (7)

0 (0)

Mobilization therapy, n (%)

1.00

 1xCAD

20 (95)

13 (93)

7 (100)

 Other

1 (5)

1 (7)

0 (0)

 Age at PBSC collection, years

59 (44–67)

57 (44–67)

59 (47–67)

0.79

 Collected CD34+ cells × 10⁶/kg

11.8 (7.4–24.8)

9.7 (7.4–24.8)

13.7 (9.1–23.0)

0.20